Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Equipment
Datasets
Search by expertise, name or affiliation
Prot# 015-00: Phase I Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (MK-0683) (L-001079038) in Combination with Bortezomib in Patients With Advanced Multiple Myeloma
Singhal, Seema
(PD/PI)
Medicine, Hematology Oncology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
4/11/06
→
4/11/09
Funding
PRA Health Sciences
(015-00)
Merck & Co., Inc.
(015-00)
View all
View less